Intellectual Property

Global protection for your ideas, products and services

As Australia continues its shift to a service-led economy, businesses face continual legislative changes.

Intellectual property laws are adapting to this rapidly changing environment, both locally and internationally, particularly as Australian patent law continues to align with European standards.

Our highly experienced and globally-connected intellectual property (IP) team works collaboratively with companies to ensure they are protected here in Australia and around the world. We work with your teams to preserve your organisation’s ideas, products, services, ensuring you make the most of the commercial opportunities open to your business, no matter where you operate.

A strong team of talented IP practitioners who dig deep to understand the problem to find the solution.

Asia Pacific Legal 500
Corrs Chambers Westgarth is one of the top practices in the Australian IP litigation market.

Asia Pacific Legal 500
Corrs’ team is incredibly responsive, commercial and pragmatic.

Asia Pacific Legal 500
They are high-quality practitioners who know the work back to front.

Chambers Asia Pacific

BP

Advising on the terms of a A$20 million research collaboration with CSIRO and other research partners related to its exploration activities.

Queensland University of Technology

Advising QUT on agreements with the Queensland Department of Transport and Main Roads and French company VEDECOM for the purchase of a vehicle and software licences, and for the conduct of autonomous vehicle software trial and collaborative research activities.

Video-based game media

Major copyright litigation involving copyright infringement and misleading and deceptive conduct in relation to location-based augmented reality games.

Lundbeck

Advised Lundbeck on its 14-year patent litigation against four generic pharmaceutical companies relating to the anti-depressant Lexapro, with success on liability and damages.

Merck Sharp & Dohme

Advising Merck Sharp & Dohme on patent litigation with Wyeth seeking to revoke patents covering Wyeth’s Prevnar 13 products (vaccines that reduce the incidence of severe ear infections in children, and pneumonia in the elderly). Wyeth has alleged infringement of these patents by the proposed launch of Merck Sharp & Dohme’s own 15-valent vaccine.